Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ian R. Phillips & Elizabeth A. Shephard. (2017) Drug metabolism by flavin-containing monooxygenases of human and mouse. Expert Opinion on Drug Metabolism & Toxicology 13:2, pages 167-181.
Read now
Read now
Yasushi Yamazoe, Kazumi Ito & Kouichi Yoshinari. (2011) Construction of a CYP2E1-template system for prediction of the metabolism on both site and preference order. Drug Metabolism Reviews 43:4, pages 409-439.
Read now
Read now
L. Chen, J. Yang, A. K. Davey, Y.-X. Chen, J.-P. Wang & X.-Q. Liu. (2009) Effects of diammonium glycyrrhizinate on the pharmacokinetics of aconitine in rats and the potential mechanism. Xenobiotica 39:12, pages 955-963.
Read now
Read now
Shu-Feng Zhou, Jun-Ping Liu & Balram Chowbay. (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews 41:2, pages 89-295.
Read now
Read now
M. D. Lee, E. Ayanoglu & L. Gong. (2006) Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions. Xenobiotica 36:10-11, pages 1013-1080.
Read now
Read now
Articles from other publishers (15)
Allyson L. Spence, Leticia A. Shea, Madalyn Kuhlenberg, Cassandra Stroup, Stephanie James & LaToya Jones Braun. 2023. Substance Use and Addiction Research. Substance Use and Addiction Research
209
231
.
Slobodan P. Rendić, Rachel D. Crouch & F. Peter Guengerich. (2022) Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions. Archives of Toxicology 96:8, pages 2145-2246.
Crossref
Crossref
Xiaoyan Pang, Chongzhuang Tang, Runcong Guo & Xiaoyan Chen. (2022) Non-cytochrome P450 enzymes involved in the oxidative metabolism of xenobiotics: Focus on the regulation of gene expression and enzyme activity. Pharmacology & Therapeutics 233, pages 108020.
Crossref
Crossref
Puneet Narang, Jacob Held & Steven Lippmann. 2020. Sleep Medicine and Mental Health. Sleep Medicine and Mental Health
101
128
.
Alexander V. LyubimovEugene G. Hrycay & Stelvio M. Bandiera. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
36
.
Annelies C. Ham, Gijsbertus Ziere, Linda Broer, Karin M.A. Swart, Anke W. Enneman, Suzanne C. van Dijk, Janneke P. van Wijngaarden, Nikita L. van der Zwaluw, Elske M. Brouwer-Brolsma, Rosalie A.M. Dhonukshe-Rutten, Natasja M. van Schoor, M. Carola Zillikens, Teun van Gelder, Oscar J. de Vries, Paul Lips, Dorly J.H. Deeg, Lisette C.P.G.M. de Groot, Albert Hofman, Renger F. Witkamp, André G. Uitterlinden, Bruno H. Stricker & Nathalie van der Velde. (2017) CYP2C9 Genotypes Modify Benzodiazepine-Related Fall Risk: Original Results From Three Studies With Meta-Analysis. Journal of the American Medical Directors Association 18:1, pages 88.e1-88.e15.
Crossref
Crossref
Prajakta S. Badri, Jennifer R. King, Akshanth R. Polepally, Barbara H. McGovern, Sandeep Dutta & Rajeev M. Menon. (2015) Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy. Clinical Pharmacokinetics 55:3, pages 275-295.
Crossref
Crossref
Jose Valdes, Douglas L. Boggs, Angela A. Boggs & Jose A. Rey. 2016. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents
471
495
.
M. Ramesh & Prasad V. Bharatam. (2014) Importance of hydrophobic parameters in identifying appropriate pose of CYP substrates in cytochromes. European Journal of Medicinal Chemistry 71, pages 15-23.
Crossref
Crossref
David E. Moody. 2012. Handbook of Drug Interactions. Handbook of Drug Interactions
25
116
.
Kenneth Klemow, Andrew Bartlow, Justin Crawford, Neil Kocher, Jay Shah & Michael Ritsick. 2011. Herbal Medicine. Herbal Medicine
211
237
.
Janine M. Hall-Porter, D. Troy Curry & James K. Walsh. (2010) Pharmacologic Treatment of Primary Insomnia. Sleep Medicine Clinics 5:4, pages 609-625.
Crossref
Crossref
Andrew D. Krystal. (2009) A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice. Sleep Medicine Reviews 13:4, pages 265-274.
Crossref
Crossref
Arun K. Tiwari, Renan P. Souza & Daniel J. Müller. (2009) Pharmacogenetics of anxiolytic drugs. Journal of Neural Transmission 116:6, pages 667-677.
Crossref
Crossref
T. Fukasawa, A. Suzuki & K. Otani. (2007) Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines. Journal of Clinical Pharmacy and Therapeutics 32:4, pages 333-341.
Crossref
Crossref